QuantiFERON-TB Gold Test Conversion Is Associated with Active Tuberculosis Development in Inflammatory Bowel Disease Patients Treated with Biological Agents: An Experience of a Medical Center in Taiwan
Taiwan has a lower prevalence of inflammatory bowel disease (IBD) and a higher prevalence of tuberculosis (TB) infection than Western countries. The aim of this study was to investigate the prevalence of latent TB (LTB) and active TB infection in IBD patients treated with biological agents. From Jan...
Saved in:
| Main Authors: | Hsiang-Chun Lai, Chia-Hsi Chang, Ken-Sheng Cheng, Tsung-Wei Chen, Yuan-Yao Tsai, Jen-Wei Chou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2019/7132875 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.
by: Chuan-Yu Hsiao, et al.
Published: (2017-01-01) -
QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients
by: Zehra Ozsoy, et al.
Published: (2025-05-01) -
Comparative evaluation of QuantiFERON-TB gold in-tube plus for Mycobacterium tuberculosis infection among adolescents in China
by: Peng Lu, et al.
Published: (2025-02-01) -
Performance of QuantiFERON TB in a student population at low risk of tuberculosis
by: Paola Molicotti, et al.
Published: (2011-11-01) -
QuantiFERON-TB supernatant-based biomarkers predicting active tuberculosis progression
by: Haoxin Xu, et al.
Published: (2025-08-01)